Arkadiusz Gajek

8PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMolecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 25, 2025
MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model.

Wiktoria Bębenek, Arkadiusz Gajek, Agnieszka Marczak

|Jan 25, 2025
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines.

Patrycja Gralewska, Łukasz Biegała, Arkadiusz Gajek

|Aug 10, 2024
Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer.

Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak

|May 24, 2024
Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors.

Łukasz Biegała, Damian Kołat, Arkadiusz Gajek

|Apr 13, 2023
Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival.

Łukasz Biegała, Arkadiusz Gajek, Agnieszka Marczak

|Jun 24, 2022
The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous BRCA and BRCA Ovarian Cancer Cells.

Patrycja Gralewska, Arkadiusz Gajek, Dorota Rybaczek

Pageof 2

Frequent Collaborators

8 joint publications

Aneta Rogalska

7 joint publications

Agnieszka Marczak

4 joint publications

Patrycja Gralewska

3 joint publications

Agnieszka Śliwińska